Literature DB >> 23886065

Developmental plasticity of murine and human Foxp3(+) regulatory T cells.

Adrian Liston1, Ciriaco A Piccirillo.   

Abstract

Murine and human CD4(+) regulatory T (Treg) cells expressing the Forkhead box p3 (Foxp3) transcription factor represent a distinct, highly differentiated CD4(+) T cell lineage that is programmed for dominant self-tolerance and control of immune responses against a variety of foreign antigens. Sustained Foxp3 expression in these cells drives the differentiation of a regulatory phenotype and ensures the stability of their suppressive functions under a variety of inflammatory settings. Some recent studies have challenged this premise and advanced the notion that Foxp3(+) Treg cells manifest a high degree of functional plasticity that enables them to adapt and reprogram into effector-like T cells in response to various inflammatory stimuli. The concept of Treg cell plasticity remains highly contentious, with a high degree of variation in measured plasticity potential observed under different experimental conditions. In this chapter, we propose a unifying model of Treg cell plasticity, which hypothesizes that the stable fates of regulatory and effector T (Teff) cell lineages allow transient plasticity into the alternative lineage under a discrete set of microenvironmental influences associated with, respectively, the initiation and resolution phases of infection. This model utilizes a theoretical framework consistent with the requirements for effective immune regulation and accounts for both the extraordinary long-term stability of Treg cells and the observed fate plasticity.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Differentiation; Epigenetics; Foxp3; Infection; Plasticity; Tolerance; Treg

Mesh:

Substances:

Year:  2013        PMID: 23886065     DOI: 10.1016/B978-0-12-407707-2.00003-5

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


  10 in total

Review 1.  Once a Treg, always a Treg?

Authors:  Deepali V Sawant; Dario A A Vignali
Journal:  Immunol Rev       Date:  2014-05       Impact factor: 12.988

Review 2.  Treg functional stability and its responsiveness to the microenvironment.

Authors:  Joseph Barbi; Drew Pardoll; Fan Pan
Journal:  Immunol Rev       Date:  2014-05       Impact factor: 12.988

Review 3.  Homeostatic control of regulatory T cell diversity.

Authors:  Adrian Liston; Daniel H D Gray
Journal:  Nat Rev Immunol       Date:  2014-01-31       Impact factor: 53.106

Review 4.  Blocking inflammation to improve immunotherapy of advanced cancer.

Authors:  Antonio Macciò; Clelia Madeddu
Journal:  Immunology       Date:  2019-12-27       Impact factor: 7.397

5.  YY1 inhibits differentiation and function of regulatory T cells by blocking Foxp3 expression and activity.

Authors:  Soo Seok Hwang; Sung Woong Jang; Min Kyung Kim; Lark Kyun Kim; Bong-Sung Kim; Hyeong Su Kim; Kiwan Kim; Wonyong Lee; Richard A Flavell; Gap Ryol Lee
Journal:  Nat Commun       Date:  2016-02-19       Impact factor: 14.919

Review 6.  Transcriptional regulation and development of regulatory T cells.

Authors:  Wonyong Lee; Gap Ryol Lee
Journal:  Exp Mol Med       Date:  2018-03-09       Impact factor: 8.718

7.  Superior Cervical Ganglia Neurons Induce Foxp3+ Regulatory T Cells via Calcitonin Gene-Related Peptide.

Authors:  Kirsten Szklany; Evelyn Ruiter; Firoz Mian; Wolfgang Kunze; John Bienenstock; Paul Forsythe; Khalil Karimi
Journal:  PLoS One       Date:  2016-03-29       Impact factor: 3.240

8.  Combining FoxP3 and Helios with GARP/LAP markers can identify expanded Treg subsets in cancer patients.

Authors:  May Abd Al Samid; Belal Chaudhary; Yazan S Khaled; Basil J Ammori; Eyad Elkord
Journal:  Oncotarget       Date:  2016-03-22

Review 9.  Clinical Tolerogenic Dendritic Cells: Exploring Therapeutic Impact on Human Autoimmune Disease.

Authors:  Brett Eugene Phillips; Yesica Garciafigueroa; Massimo Trucco; Nick Giannoukakis
Journal:  Front Immunol       Date:  2017-10-12       Impact factor: 7.561

10.  Loss of Lkb1 impairs Treg function and stability to aggravate graft-versus-host disease after bone marrow transplantation.

Authors:  Xiuhua Su; Qianqian Wang; Wei Guo; Xiaolei Pei; Qing Niu; Maolan Liu; Yuanyuan Liu; Song Chen; Sizhou Feng; Yi He; Donglin Yang; Rongli Zhang; Qiaoling Ma; Weihua Zhai; Aiming Pang; Jialin Wei; Yong Huang; Yuechen Luo; Mingzhe Han; Xiaoming Feng; Erlie Jiang
Journal:  Cell Mol Immunol       Date:  2019-10-29       Impact factor: 11.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.